![]() |
|||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Gene: TMX2 |
Gene summary for TMX2 |
![]() |
Gene information | Species | Human | Gene symbol | TMX2 | Gene ID | 51075 |
Gene name | thioredoxin related transmembrane protein 2 | |
Gene Alias | CGI-31 | |
Cytomap | 11q12.1 | |
Gene Type | protein-coding | GO ID | GO:0007275 | UniProtAcc | Q9Y320 |
Top |
Malignant transformation analysis |
![]() |
![]() |
Entrez ID | Symbol | Replicates | Species | Organ | Tissue | Adj P-value | Log2FC | Malignancy |
51075 | TMX2 | HTA11_3410_2000001011 | Human | Colorectum | AD | 8.06e-10 | 2.08e-01 | 0.0155 |
51075 | TMX2 | HTA11_2487_2000001011 | Human | Colorectum | SER | 7.90e-11 | 3.00e-01 | -0.1808 |
51075 | TMX2 | HTA11_1938_2000001011 | Human | Colorectum | AD | 4.00e-12 | 3.82e-01 | -0.0811 |
51075 | TMX2 | HTA11_78_2000001011 | Human | Colorectum | AD | 1.86e-16 | 4.42e-01 | -0.1088 |
51075 | TMX2 | HTA11_347_2000001011 | Human | Colorectum | AD | 5.41e-38 | 6.42e-01 | -0.1954 |
51075 | TMX2 | HTA11_411_2000001011 | Human | Colorectum | SER | 1.20e-07 | 5.05e-01 | -0.2602 |
51075 | TMX2 | HTA11_2112_2000001011 | Human | Colorectum | SER | 1.50e-04 | 3.37e-01 | -0.2196 |
51075 | TMX2 | HTA11_3361_2000001011 | Human | Colorectum | AD | 6.03e-08 | 3.09e-01 | -0.1207 |
51075 | TMX2 | HTA11_83_2000001011 | Human | Colorectum | SER | 1.71e-21 | 5.64e-01 | -0.1526 |
51075 | TMX2 | HTA11_696_2000001011 | Human | Colorectum | AD | 2.92e-23 | 4.31e-01 | -0.1464 |
51075 | TMX2 | HTA11_866_2000001011 | Human | Colorectum | AD | 4.93e-21 | 3.77e-01 | -0.1001 |
51075 | TMX2 | HTA11_1391_2000001011 | Human | Colorectum | AD | 2.12e-26 | 6.11e-01 | -0.059 |
51075 | TMX2 | HTA11_2992_2000001011 | Human | Colorectum | SER | 2.14e-07 | 4.65e-01 | -0.1706 |
51075 | TMX2 | HTA11_5212_2000001011 | Human | Colorectum | AD | 6.52e-06 | 2.80e-01 | -0.2061 |
51075 | TMX2 | HTA11_5216_2000001011 | Human | Colorectum | SER | 3.22e-05 | 3.63e-01 | -0.1462 |
51075 | TMX2 | HTA11_546_2000001011 | Human | Colorectum | AD | 6.66e-12 | 4.68e-01 | -0.0842 |
51075 | TMX2 | HTA11_7862_2000001011 | Human | Colorectum | AD | 3.08e-04 | 2.52e-01 | -0.0179 |
51075 | TMX2 | HTA11_866_3004761011 | Human | Colorectum | AD | 3.29e-15 | 3.30e-01 | 0.096 |
51075 | TMX2 | HTA11_4255_2000001011 | Human | Colorectum | SER | 3.34e-04 | 3.36e-01 | 0.0446 |
51075 | TMX2 | HTA11_7663_2000001011 | Human | Colorectum | SER | 7.58e-09 | 4.07e-01 | 0.0131 |
Page: 1 2 3 4 5 6 7 8 |
![]() |
∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage. |
Top |
Malignant transformation related pathway analysis |
![]() |
![]() |
Tissue | Disease Stage | Enriched GO biological Processes |
Colorectum | AD | ![]() |
Colorectum | SER | ![]() |
Colorectum | MSS | ![]() |
Colorectum | MSI-H | ![]() |
Colorectum | FAP | ![]() |
∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust). |
Page: 1 2 3 4 5 6 7 8 9 |
![]() |
GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
Page: 1 |
![]() |
Pathway ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | qvalue | Count |
Page: 1 |
Top |
Cell-cell communication analysis |
![]() |
Ligand | Receptor | LRpair | Pathway | Tissue | Disease Stage |
Page: 1 |
Top |
Single-cell gene regulatory network inference analysis |
![]() |
TF | Cell Type | Tissue | Disease Stage | Target Gene | RSS | Regulon Activity |
∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression. |
Page: 1 |
Top |
Somatic mutation of malignant transformation related genes |
![]() |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
TMX2 | SNV | Missense_Mutation | novel | c.203N>G | p.Ile68Ser | p.I68S | Q9Y320 | protein_coding | deleterious(0) | probably_damaging(0.983) | TCGA-B5-A3FA-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD |
TMX2 | SNV | Missense_Mutation | rs369636517 | c.269N>C | p.Ile90Thr | p.I90T | Q9Y320 | protein_coding | deleterious(0.01) | benign(0.084) | TCGA-BG-A222-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Unknown | Unknown | SD |
TMX2 | SNV | Missense_Mutation | c.179N>G | p.Asp60Gly | p.D60G | Q9Y320 | protein_coding | tolerated(0.05) | benign(0.184) | TCGA-BS-A0UF-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD | |
TMX2 | SNV | Missense_Mutation | novel | c.483N>T | p.Glu161Asp | p.E161D | Q9Y320 | protein_coding | tolerated(0.06) | probably_damaging(0.999) | TCGA-BS-A0UJ-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD |
TMX2 | SNV | Missense_Mutation | novel | c.760N>A | p.Glu254Lys | p.E254K | Q9Y320 | protein_coding | tolerated(0.34) | possibly_damaging(0.622) | TCGA-EO-A22R-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Unknown | Unknown | SD |
TMX2 | SNV | Missense_Mutation | c.719N>A | p.Arg240Gln | p.R240Q | Q9Y320 | protein_coding | tolerated(0.1) | benign(0.416) | TCGA-EY-A215-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Unknown | Unknown | SD | |
TMX2 | SNV | Missense_Mutation | novel | c.419A>G | p.Tyr140Cys | p.Y140C | Q9Y320 | protein_coding | deleterious(0) | probably_damaging(0.997) | TCGA-FI-A2D5-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | III/IV | Chemotherapy | carboplatinum | PD |
TMX2 | SNV | Missense_Mutation | novel | c.814G>T | p.Asp272Tyr | p.D272Y | Q9Y320 | protein_coding | deleterious(0.01) | possibly_damaging(0.73) | TCGA-FI-A2D5-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | III/IV | Chemotherapy | carboplatinum | PD |
TMX2 | deletion | Frame_Shift_Del | novel | c.868delN | p.Glu291LysfsTer83 | p.E291Kfs*83 | Q9Y320 | protein_coding | TCGA-B5-A1MX-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Hormone Therapy | megace | SD | ||
TMX2 | insertion | Frame_Shift_Ins | novel | c.384_385insC | p.Leu131ProfsTer6 | p.L131Pfs*6 | Q9Y320 | protein_coding | TCGA-DF-A2KN-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | Unknown | I/II | Unknown | Unknown | SD |
Page: 1 2 3 4 |
Top |
Related drugs of malignant transformation related genes |
![]() |
(DGIdb 4.0) |
Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
51075 | TMX2 | THIOREDOXIN, DRUGGABLE GENOME | ethanol | ALCOHOL | 32451486 |
Page: 1 |